Updated Jul 16, 2026
Hagen Brett R is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $16K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-23 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 1.9K | $6.72 | $13K |
| 2024-11-20 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 554 | $0.55 | $304 |
| 2024-11-06 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 1.7K | $0.86 | $1K |
| 2024-10-23 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 486 | $0.77 | $373 |
| 2024-10-23 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 479 | $0.78 | $373 |
| 2024-10-04 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 301 | $0.81 | $245 |
Hagen Brett R is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($16K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hagen Brett R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.